Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey

By Sucak Gülsan Türköz   Çakar Merih Kızıl   Suyanı Elif   Akı Zeynep   Altındal Şermin   Acar Kadir  

Hematology, Vol. 18, Iss. 5, 2013-09 ,pp. : 269-276

Maney Publishing

Access to resources Recommend Favorite

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

By Sieniawski Michal   Staak Oliver   Glossmann Jan-Peter   Reineke Thorsten   Scheuß Helena   Diehl Volker   Engert Andreas   Josting Andreas  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 107-115

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

By Lee Ming-Yang  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 285-289

Springer Publishing Company

Access to resources Recommend Favorite

Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Diffuse Large B Cell Lymphoma

By  

Current Stem Cell Research & Therapy, Vol. 12, Iss. 1, 2016-12 ,pp. : 14-18

Bentham Science Publishers

Access to resources Recommend Favorite

Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patients

By Holowiecki J.   Giebel S.   Wojnar J.   Krawczyk-Kulis M.   Stella-Holowiecka B.   Kachel L.   Wojciechowska M.   Markiewicz M.   Kata D.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3378-3383

Elsevier

Access to resources Recommend Favorite